Description

Denigma (memantine) Coated Tablets 10 mg. №140

Ingredients

Active ingredient: Memantine hydrochloride. Other ingredients include microcrystalline cellulose, colloidal silicon dioxide, talc, and magnesium stearate.

Dosage

Recommended dosage: The usual starting dose is 5 mg once daily. The dose is then increased by 5 mg at weekly intervals. The maximum recommended dose is 20 mg per day.

Indications

Denigma (memantine) Coated Tablets are indicated for the treatment of moderate to severe Alzheimer’s disease.

Contraindications

Do not use Denigma (memantine) Coated Tablets if:

• You are allergic to memantine or any other ingredients in the product.
• You have severe kidney problems.
• You are pregnant or breastfeeding.

Directions

Take Denigma (memantine) Coated Tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with water. Do not crush or chew the tablet.

Scientific Evidence

Scientific studies have shown that memantine, the active ingredient in Denigma tablets, can help improve cognitive function and slow down the progression of Alzheimer’s disease. Research published in the Journal of Alzheimer’s Disease demonstrated the efficacy of memantine in improving memory and daily functioning in patients with Alzheimer’s.

Additional Information

It is important to follow your healthcare provider’s instructions carefully while taking Denigma (memantine) Coated Tablets. Inform your doctor about any other medications you are taking to avoid potential drug interactions.

Pharmacological Effects: Memantine works by regulating the activity of glutamate, a neurotransmitter involved in learning and memory. By blocking excessive glutamate activity, memantine helps protect brain cells from damage in Alzheimer’s disease.

Clinical Trials: Clinical trials have shown that memantine is well-tolerated and effective in improving cognitive function and behavior in patients with Alzheimer’s disease. A study published in the New England Journal of Medicine reported that memantine treatment resulted in significant improvements in cognitive and functional abilities compared to a placebo.